Giovanni Chinellato

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

CliniRx (India)(Current)

Newron Pharmaceuticals (Italy)

Giovanni Chinellato is an author at CliniRx (India) specializing in add-on therapy, long-term efficacy evaluation, and last observation carried forward.

ORCID

Publications per year

2023–2024

Publications

Phase 2 Results Indicate Evenamide, A Selective Modulator of Glutamate Release, Is Associated With Clinically Important Long-Term Efficacy When Added to an Antipsychotic in Patients With Treatment-Resistant Schizophrenia

Ravi Anand, Alessio Turolla, Giovanni Chinellato et al. · The International Journal of Neuropsychopharmacology · 2023 · 22 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy and safety of evenamide, a glutamate modulator, added to a second-generation antipsychotic in inadequately/poorly responding patients with chronic schizophrenia: Results from a randomized, double-blind, placebo-controlled, phase 3, international clinical trial

Ravi Anand, Alessio Turolla, Giovanni Chinellato et al. · Neuropharmacology · 2024 · 12 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

1–2 of 2